医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Demand for Temperature-Sensitive Pharmaceuticals Will Expand the Healthcare Cold Chain Logistics Market by 2019, Says TechNavio

2014年12月17日 AM12:35
このエントリーをはてなブックマークに追加


 

LONDON

TechNavio, a tech-focused research firm, has published a new report on the Global Healthcare Cold Chain Logistics Market, which is expected to grow at a CAGR of 13.31 percent from 2014-2019.

Developing economies are witnessing an increased demand for generic pharmaceutical products. This scenario has created a pressing need for temperature-sensitive healthcare transportation with the use of temperature tags on products.

“Recently, there’s been an increase in the demand for temperature-sensitive pharmaceuticals, and this is expected to propel the demand for cold chain logistics in the coming years,” says Faisal Ghaus, Vice President of TechNavio.

Healthcare products such as vaccines and blood plasma, frozen pharmaceuticals and insulin require specific temperatures to be maintained throughout storage and transportation.

Increased investment in cost-effective technologies in developing markets, especially India, is motivating vendors to enter this region.

There’s been an increase in healthcare infrastructure and investment in technologies to match these requirements. Additionally, there has been an emergence of transport vehicles equipped with event logging and electronic monitoring systems, which has enhanced the healthcare supply chain process.

TechNavio currently has more than 3000 market research reports on a huge range of topics, including:

About TechNavio

TechNavio is a leading global technology research and advisory company.

Founded in 2003, TechNavio has about 200 analysts globally and develops over 2000 pieces of research every year, covering more than 500 technologies across 80 countries.

TechNavio analysts employ primary as well as secondary research techniques to ascertain the size and vendor landscape in a range of markets. Analysts obtain information using a combination of bottom-up and top-down approaches, besides using in-house market modeling tools and proprietary databases. They corroborate this data with the data obtained from various market participants and stakeholders across the value chain, including vendors, service providers, distributors, re-sellers, and end-users.

If you are interested in more information, please contact our media team at media@technavio.com.

CONTACT

TechNavio Research
Jes Ellacott
US: +1-630-333-9501
UK:
+44 208 123 1770
Media & Marketing Executive
www.technavio.com
media@technavio.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • BioVectra与Keryx Biopharmaceuticals签署枸橼酸铁扩产协议
  • Eternity Healthcare Inc. Enters into Share Exchange Agreement with Guizho Tongren Healthy China Biotechnology Co. Ltd.
  • Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn’s disease
  • Chi-Med Initiates Fruquintinib U.S. Clinical Trials
  • Orthocell Granted European Tendon Regeneration Patent